- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02848612
Evaluation of the Amiens University Hospital Neuroradiology Anticoagulation Protocol (ANTICONEURORAD)
October 11, 2018 updated by: Centre Hospitalier Universitaire, Amiens
To prevent thromboembolic complications, the embolization procedure is performed under prophylactic unfractionated heparin, the efficacy of which is monitored by point-of- care testing according to international guidelines.
However, these guidelines are based on limited scientific evidence and the ideal level of anticoagulation required has not been precisely defined.
Furthermore, the correlation between the point-of- care tests used at Amiens University Hospital and the reference methods used in the laboratory varies considerably according to the available literature.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Since the beginning of the 2000s, the reference treatment for the management of aneurysmal subarachnoid haemorrhage consists of interventional neuroradiology with coil embolization of the aneurysm.
Although ensuring a better neurological prognosis than neurosurgical clipping, interventional neuroradiology exposes the patient to various risks: thromboembolic complications during or after embolization and re-rupture of the aneurysm during embolization.
To prevent thromboembolic complications, the embolization procedure is performed under prophylactic unfractionated heparin, the efficacy of which is monitored by point-of- care testing according to international guidelines.
However, these guidelines are based on limited scientific evidence and the ideal level of anticoagulation required has not been precisely defined.
Furthermore, the correlation between the point-of- care tests used at Amiens University Hospital and the reference methods used in the laboratory varies considerably according to the available literature.
Study Type
Observational
Enrollment (Actual)
459
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Amiens, France, 80054
- CHU Amiens
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients over the age of 18 years undergoing one of the following interventional neuroradiology procedures at Amiens University Hospital: elective embolization of an intracranial aneurysm, emergency embolization of a ruptured intracranial aneurysm, elective or urgent embolization of an intracranial or perispinal arteriovenous malformation.
Description
Inclusion Criteria:
- Patients over the age of 18 years undergoing one of the following interventional neuroradiology procedures at Amiens University Hospital: elective embolization of an intracranial aneurysm, emergency embolization of a ruptured intracranial aneurysm, elective or urgent embolization of an intracranial or perispinal arteriovenous malformation.
Exclusion Criteria:
- Patients in whom all modalities of monitoring of the efficacy of anticoagulation (laboratory tests and point-of-care tests) were not performed, incomplete embolization or radiological follow-up records.
- Patients presenting a contraindication to the administration of unfractionated heparin: history of heparin-induced thrombocytopenia or haemorrhagic coagulopathy (von Willebrand disease, haemophilia).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
correlation between laboratory clotting tests and point-of-care clotting tests
Time Frame: 6 months
|
evaluation of the correlation between laboratory clotting tests and point-of-care clotting tests performed on the Hemochron Junior® device. care clotting tests and laboratory tests in the setting of intracranial embolization. |
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 20, 2015
Primary Completion (Actual)
July 15, 2016
Study Completion (Actual)
July 15, 2016
Study Registration Dates
First Submitted
July 26, 2016
First Submitted That Met QC Criteria
July 26, 2016
First Posted (Estimate)
July 28, 2016
Study Record Updates
Last Update Posted (Actual)
October 12, 2018
Last Update Submitted That Met QC Criteria
October 11, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RNI2015-13 Pr Lorne
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aneurysm
-
University of BolognaCompletedThoracoabdominal Aortic Aneurysm | Ruptured Thoracic Aneurysm | Ruptured Aortic Aneurysm | Thoracoabdominal Aortic Aneurysm, RupturedItaly
-
Karolinska University HospitalKarolinska Institutet; Swedish Heart Lung FoundationActive, not recruitingAortic Aneurysm | Aortic Aneurysm Abdominal | Abdominal AneurysmSweden
-
University of North Carolina, Chapel HillCook Group Incorporated; UNC HospitalsEnrolling by invitationAortic Aneurysm, Abdominal | Aortic Arch Aneurysm | Ascending Aorta AneurysmUnited States
-
W.L.Gore & AssociatesCMIC Co, Ltd. JapanRecruitingThoracoabdominal Aortic Aneurysm | Pararenal Aortic AneurysmJapan
-
IRCCS San RaffaeleCompletedAneurysm Thoracic | Aneurysm Abdominal | Renal AneurysmUnited States, France, Italy, United Kingdom, Germany, Spain, Denmark, Sweden
-
CEVARIIUniversity of Colorado, Denver; University of Copenhagen; University of Iowa; University... and other collaboratorsEnrolling by invitationComplex EVAR in Inflammatory and Infective Abdominal and Thoracoabdominal Aortic Aneurysms (CEVARII)Abdominal Aortic Aneurysm | Thoracoabdominal Aortic Aneurysm | Aneurysm, Infected | Inflammatory Abdominal Aortic Aneurysm | Aneurysm, MycoticUnited States
-
Karolinska University HospitalEnrolling by invitationAneurysm | Aortic Aneurysm | Abdominal Aortic Aneurysm, Ruptured | Aneurysm Abdominal | Abdominal Aortic Aneurysm Without RuptureSweden
-
Cook Research IncorporatedCompletedAbdominal Aortic Aneurysm (AAA) | Aorto-iliac Aneurysm | Juxtarenal AneurysmUnited States
-
University Hospital of LimerickCompleted
-
The Christ HospitalMedtronicRecruiting
Clinical Trials on anticoagulation by unfractionated heparin
-
University Medical Centre LjubljanaNot yet recruitingRenal Failure | End-Stage Kidney Disease | Hemodiafiltration | Chronic HemodialysisSlovenia
-
Chen JingHanyang University; Renmin Hospital of Wuhan University; The Second Affiliated... and other collaboratorsRecruitingST-elevation Myocardial Infarction (STEMI) | Primary PCIChina
-
Rajaie Cardiovascular Medical and Research CenterBrigham and Women's Hospital; Tehran Heart Center; Imam Khomeini Hospital; Masih... and other collaboratorsCompletedCovid19Iran, Islamic Republic of
-
Hospices Civils de LyonUnknownSeptic ShockFrance
-
Allied Hospital FaisalabadNot yet recruiting
-
Robert F. JamesIndiana University School of MedicineSuspendedNeurobehavioral Manifestations | Aneurysmal Subarachnoid Hemorrhage | Vasospasm, Intracranial | Intracranial Aneurysm | Heparin-induced Thrombocytopenia Type IIUnited States
-
Christine RibicMcMaster University; LEO PharmaCompleted
-
Vanderbilt UniversityTerminatedHeart Failure | Acute Kidney Injury | Acute Renal FailureUnited States
-
Baylor Research InstituteActive, not recruitingRespiratory Failure | Heparin | ECMOUnited States
-
University of PatrasCompletedCoronary AngiographyGreece